Skip to Main Content

Good morning, everyone, and nice to see you again after we disappeared for a needed break. And we hope your own respite this past weekend was invigorating and refreshing, because that oh-so-familiar routine of phone calls, online meetings, and deadlines has predictably returned. But what can we do? The world, such as it is, continues to spin. So time to give it a nudge in a better direction with a cup or three of stimulation. Our choice today is bananas Foster, a sweet start to the day. Feel free to join us. Meanwhile, here is the latest list of interesting items as we play a bit of catch-up. Hope your journey goes well today, and, of course, do keep in touch. …

Perrigo has submitted an application to the U.S. Food and Drug Administration for approval of an over-the-counter birth control pill, Reuters writes. The application from its HRA Pharma unit comes after the U.S. Supreme Court last month overturned the Roe v. Wade ruling that legalized abortion nationwide. If approved, the contraceptive, which is currently a prescription drug known as Opill, would be the first daily birth control pill available without a prescription in the U.S. The non-estrogen pill has been used since it was approved by the FDA in 1973. Perrigo said scientific evidence has shown progestin-only pills are effective at preventing pregnancy and safe for most women to use.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment